{"id":"https://openalex.org/W4297944786","doi":"https://doi.org/10.2174/092986730609220401151459","title":"Role of Neurotrophin-Trk Interactions in Oncology: The Anti-tumor Efficacy of Potent and Selective Trk Tyrosine Kinase Inhibitors in Pre-Clinical Tumor Models","display_name":"Role of Neurotrophin-Trk Interactions in Oncology: The Anti-tumor Efficacy of Potent and Selective Trk Tyrosine Kinase Inhibitors in Pre-Clinical Tumor Models","alternate_titles":[],"publication_year":1999,"publication_date":"1999-09-01","ids":{"openalex":"https://openalex.org/W4297944786","doi":"https://doi.org/10.2174/092986730609220401151459","mag":"2949512534","pmid":"https://pubmed.ncbi.nlm.nih.gov/10495355"},"language":"en","primary_location":{"id":"doi:10.2174/092986730609220401151459","doi":"https://doi.org/10.2174/092986730609220401151459","is_oa":false,"landing_page_url":"https://doi.org/10.2174/092986730609220401151459","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4297944786"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036665836","display_name":"Bruce Ruggeri","orcid":"https://orcid.org/0009-0002-0095-873X","observed_orcids":["https://orcid.org/0009-0002-0095-873X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bruce A. Ruggeri","raw_affiliation_strings":["Cephalon, Inc., 145 Brandywine Parkway, West Chester, PA 19380, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cephalon, Inc., 145 Brandywine Parkway, West Chester, PA 19380, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048824509","display_name":"Shelia J. Miknyoczki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shelia J. Miknyoczki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jasbir Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jasbir Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066909701","display_name":"Robert L. Hudkins","orcid":"https://orcid.org/0009-0008-8250-7679","observed_orcids":["https://orcid.org/0009-0008-8250-7679"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Hudkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5036665836"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7356,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.62189749,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"6","issue":"9","first_page":"845","last_page":"857"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.6157000064849854,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.6157000064849854,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.29829999804496765,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/signaling-pathways","display_name":"signaling pathways","score":0.7940000295639038},{"id":"https://openalex.org/keywords/oral-tyrosine-kinase-inhibitor","display_name":"oral tyrosine kinase inhibitor","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C134139212","wikidata":"https://www.wikidata.org/wiki/Q24719927","display_name":"Trk receptor","level":4,"score":0.97337806224823},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.6408711671829224},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6053587198257446},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5817672610282898},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.5452190041542053},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.47355523705482483},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4627542495727539},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4502536356449127},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43304887413978577},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38041093945503235},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3725772202014923},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3364681601524353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24228599667549133},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10057595372200012}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009414","descriptor_name":"Nerve Growth Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D026121","descriptor_name":"Indole Alkaloids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/092986730609220401151459","doi":"https://doi.org/10.2174/092986730609220401151459","is_oa":false,"landing_page_url":"https://doi.org/10.2174/092986730609220401151459","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:10495355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10495355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"},{"id":"mag:2949512534","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10495355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1969153167","https://openalex.org/W2130348198","https://openalex.org/W2943131729","https://openalex.org/W2066887304","https://openalex.org/W2752375057","https://openalex.org/W2282636056","https://openalex.org/W3112870552","https://openalex.org/W3036440433","https://openalex.org/W2558097919","https://openalex.org/W2006371036"],"abstract_inverted_index":{"The":[0,50],"increasing":[1],"knowledge":[2],"of":[3,16,44,53,90,110,119],"the":[4,14,24,88,91,111,117,120,130],"pathogenic":[5],"mechanisms":[6],"involved":[7],"in":[8,42,48,60,103,116],"cancer":[9],"cell":[10],"growth":[11],"has":[12,63,80],"enabled":[13],"implementation":[15],"mechanism":[17],"based":[18],"drug":[19],"design":[20],"approaches":[21],"rather":[22],"than":[23],"more":[25],"conventional":[26],"nonspecific":[27],"approaches.":[28],"Drugs":[29],"that":[30],"interfere":[31],"with":[32],"cellular":[33],"signal":[34],"transduction":[35],"pathways":[36],"are":[37],"currently":[38],"a":[39,75,95],"major":[40],"focus":[41],"development":[43],"newer":[45],"therapeutic":[46,51],"technologies":[47],"oncology.":[49],"utility":[52],"potent":[54,122],"and":[55,129],"selective":[56],"tyrosine":[57,124],"kinase":[58,125],"inhibitors":[59],"oncologic":[61],"applications":[62],"become":[64],"widely":[65],"recognized":[66],"for":[67,99],"several":[68],"years,":[69],"however":[70],"targeting":[71],"neurotrophin":[72],"receptors":[73,93],"as":[74,94],"molecular":[76,97],"target":[77,98],"driven":[78],"approach":[79],"only":[81],"recently":[82],"been":[83],"realized.":[84],"This":[85],"review":[86],"presents":[87],"hypothesis":[89],"neurotrophin-trk":[92],"viable":[96],"medicinal":[100],"chemical":[101],"intervention":[102],"tumor":[104],"biology,":[105],"followed":[106],"by":[107],"an":[108],"overview":[109],"pre-clinical":[112],"studies":[113],"which":[114],"culminated":[115],"advancement":[118],"first":[121],"trk":[123],"inhibitor":[126],"CEP-2563":[127],"(KT-8391),":[128],"orally":[131],"active":[132],"K-252a":[133],"analog,":[134],"CEP-701":[135],"(KT-5555)":[136],"into":[137],"clinical":[138],"evaluation.":[139]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4297944786","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-10-01T00:00:00"}
